Poland · Delayed Price · Currency is PLN Krynica Vitamin Statistics
Total Valuation
Krynica Vitamin has a market cap or net worth of PLN 126.79 million. The enterprise value is 159.99 million.
| Market Cap | 126.79M |
| Enterprise Value | 159.99M |
Important Dates
The next estimated earnings date is Monday, November 24, 2025.
| Earnings Date | Nov 24, 2025 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
Krynica Vitamin has 12.25 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 12.25M |
| Shares Outstanding | 12.25M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 1.92% |
| Float | 1.61M |
Valuation Ratios
The trailing PE ratio is 8.72.
| PE Ratio | 8.72 |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 1.29 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | 6.36 |
| P/OCF Ratio | 4.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.33, with an EV/FCF ratio of 8.02.
| EV / Earnings | 11.00 |
| EV / Sales | 0.41 |
| EV / EBITDA | 4.33 |
| EV / EBIT | 6.99 |
| EV / FCF | 8.02 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.94 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.31 |
| Debt / FCF | 2.43 |
| Interest Coverage | 8.62 |
Financial Efficiency
Return on equity (ROE) is 15.75% and return on invested capital (ROIC) is 9.95%.
| Return on Equity (ROE) | 15.75% |
| Return on Assets (ROA) | 6.04% |
| Return on Invested Capital (ROIC) | 9.95% |
| Return on Capital Employed (ROCE) | 19.28% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 41,784 |
| Employee Count | 348 |
| Asset Turnover | 1.63 |
| Inventory Turnover | 7.64 |
Taxes
In the past 12 months, Krynica Vitamin has paid 2.58 million in taxes.
| Income Tax | 2.58M |
| Effective Tax Rate | 15.06% |
Stock Price Statistics
The stock price has increased by +3.50% in the last 52 weeks. The beta is -0.13, so Krynica Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | +3.50% |
| 50-Day Moving Average | 9.87 |
| 200-Day Moving Average | 9.52 |
| Relative Strength Index (RSI) | 62.60 |
| Average Volume (20 Days) | 3,059 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krynica Vitamin had revenue of PLN 386.55 million and earned 14.54 million in profits. Earnings per share was 1.19.
| Revenue | 386.55M |
| Gross Profit | 68.16M |
| Operating Income | 22.89M |
| Pretax Income | 17.12M |
| Net Income | 14.54M |
| EBITDA | 36.92M |
| EBIT | 22.89M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 15.33 million in cash and 48.53 million in debt, giving a net cash position of -33.20 million or -2.71 per share.
| Cash & Cash Equivalents | 15.33M |
| Total Debt | 48.53M |
| Net Cash | -33.20M |
| Net Cash Per Share | -2.71 |
| Equity (Book Value) | 97.96M |
| Book Value Per Share | 8.00 |
| Working Capital | -6.63M |
Cash Flow
In the last 12 months, operating cash flow was 29.11 million and capital expenditures -9.16 million, giving a free cash flow of 19.95 million.
| Operating Cash Flow | 29.11M |
| Capital Expenditures | -9.16M |
| Free Cash Flow | 19.95M |
| FCF Per Share | 1.63 |
Margins
Gross margin is 17.63%, with operating and profit margins of 5.92% and 3.76%.
| Gross Margin | 17.63% |
| Operating Margin | 5.92% |
| Pretax Margin | 4.43% |
| Profit Margin | 3.76% |
| EBITDA Margin | 9.55% |
| EBIT Margin | 5.92% |
| FCF Margin | 5.16% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.61%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 2.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.60% |
| Earnings Yield | 11.47% |
| FCF Yield | 15.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Krynica Vitamin has an Altman Z-Score of 2.47 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 7 |